Navigation Links
WellPoint Recovers and Saves $75 Million Through Anti-Fraud Programs and Investigations in 2008
Date:7/1/2009

84 cases referred to law enforcement; 21 criminal convictions secured

INDIANAPOLIS, July 1 /PRNewswire/ --WellPoint, Inc. (NYSE: WLP) announced today that its Fraud and Abuse department, working with its affiliated health plans, recovered and saved almost $75 million in 2008 as a result of its anti-fraud efforts. These efforts led to 84 case referrals to law enforcement and/or licensing agencies.

This announcement comes the day after the Blue Cross and Blue Shield Association announced that its health care plans' anti-fraud investigations resulted in savings and recoveries of nearly $350 million in 2008, an increase of 43 percent from 2007. There were 1,087 cases referred to law enforcement agencies and licensing authorities, and 252 convictions and 140 civil actions, settlements and judgments. WellPoint, an independent licensee of the Blue Cross and Blue Shield Association, serves members through its Blue-licensed subsidiaries and their affiliates in 14 states.

Health care fraud is a serious problem that steals at least $68 billion every year, accounting for at least 3 percent of the total amount spent on health care annually, according to the National Health Care Anti-Fraud Association. Health care fraud is dangerous as well as expensive as it can involve unnecessary and excessive surgeries, procedures and prescriptions. WellPoint's affiliated health plans are committed to leading the fight in their local markets and working cooperatively with local law enforcement and other organizations.

"These anti-fraud results exemplify one way we can work toward the goal of decreasing health care costs through careful review of health care charges," said Lee Arian, WellPoint staff vice president for Fraud and Abuse. "These efforts have proven successful in uncovering and eliminating significant fraud
'/>"/>

SOURCE WellPoint, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. WellPoint Teams up with Bob Harper from The Biggest Loser to Expand Efforts Aimed at Improving Individuals Health
2. WellPoint Captures Gold for Its Associate Wellness Program
3. WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety, Efficacy and Compliance for Medicaid Members
4. WellPoint to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 29, 2009
5. Woman Whose Health Insurance Was Cancelled by Blue Cross/WellPoint After She Got Sick Urges Congress to Protect Innocent Patients
6. IDGs Computerworld Names WellPoint to Annual List of Best Places to Work in Information Technology
7. Express Scripts Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of WellPoints NextRx Subsidiaries
8. WellPoint Announces Appearances at Upcoming Conferences
9. WellPoint Institute of Health Care Knowledge Releases Report on Health Care Costs
10. American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program
11. WellPoint Statement on Senate Finance Committee Health Reform Options Paper
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 1New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 2New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 3New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 4Outpatient disc treatment gives long term back pain relief 62403 1Outpatient disc treatment gives long term back pain relief 62403 2State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 1State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 2State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 3